The Bear implant, from Miach Orthopaedics, does not require a second surgical wound to remove a healthy tendon from the leg, according to the company. It acts as a bridge between the two ends of a torn ACL, and the implant is absorbed into the body within eight weeks, the release said.
The Bear implant received de novo approval from the FDA in December 2020.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
